Search
for
Sort by
Research 121–150 of 1000+
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Safety and efficacy of actinic keratoses reduction with a 3 day application of ingenol disoxate field treatment to the face, chest and balding scalp
- Baricitinib: A Review in Severe Alopecia Areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- To evaluate the Safety and Efficacy of Vedistry Amla + Tablets as a supplement for Healthy Hair
- Current best evidence in pigmentary dermatology
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Use of Exosomes in Hair Therapy: A Systematic Review
- Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
- Concurrence of giant cell arteritis in a patient with de quervain's thyroiditis
- Beneficial effect of spironolactone on androgenic alopecia
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Thymosin β4 Promotes Dermal Healing
- Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action
- The Potential Role of Exosomes in Aesthetic Plastic Surgery: A Review of Current Literature
- A Review On Minoxidil a Potent Hair growth Agent
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- Faculty Opinions recommendation of Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth.
- ISIDLB1680 - Effects of Ganoderma Lucidum extract and its active component, ganoderic acid A on hair loss prevention
- Sanguisorba Officinalis Root Extract Has FGF-5 Inhibitory Activity and Reduces Hair Loss by Causing Prolongation of the Anagen Period
- Trajectories For Scalp Hair Regrowth In Patients With Severe Alopecia Areata Treated With Baricitinib
- The role of mimicking growth factors to control anagen phase: Evaluation in vitro and in vivo
- 593 Low versus high fluence light-induced hair removal: How hair follicle ex vivo studies translate into clinical results
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia